Humana Options Trading: A Deep Dive into Market Sentiment

High-rolling investors have positioned themselves bullish on Humana HUM, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in HUM often signals that someone has privileged information.

Today, Benzinga's options scanner spotted 8 options trades for Humana. This is not a typical pattern.

The sentiment among these major traders is split, with 50% bullish and 25% bearish. Among all the options we identified, there was one put, amounting to $40,080, and 7 calls, totaling $265,127.

Predicted Price Range

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $340.0 for Humana over the recent three months.

Analyzing Volume & Open Interest

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Humana's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Humana's substantial trades, within a strike price spectrum from $300.0 to $340.0 over the preceding 30 days.

Humana Option Activity Analysis: Last 30 Days

Significant Options Trades Detected:

About Humana

Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Following our analysis of the options activities associated with Humana, we pivot to a closer look at the company's own performance.

Present Market Standing of Humana

• With a trading volume of 704,174, the price of HUM is up by 0.85%, reaching $337.51.
• Current RSI values indicate that the stock is may be approaching overbought.
• Next earnings report is scheduled for 82 days from now.

What Analysts Are Saying About Humana

In the last month, 5 experts released ratings on this stock with an average target price of $358.0.

• Maintaining their stance, an analyst from Cantor Fitzgerald continues to hold a Neutral rating for Humana, targeting a price of $360.
• An analyst from UBS has decided to maintain their Neutral rating on Humana, which currently sits at a price target of $326.
• An analyst from RBC Capital persists with their Outperform rating on Humana, maintaining a target price of $353.
• Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Humana, targeting a price of $381.
• Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Humana with a target price of $370.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Humana, Benzinga Pro gives you real-time options trades alerts.